Suppr超能文献

相似文献

1
Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling.
Genet Med. 2013 Feb;15(2):146-9. doi: 10.1038/gim.2012.107. Epub 2012 Aug 30.
2
Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.
JAMA Neurol. 2014 Jun;71(6):752-7. doi: 10.1001/jamaneurol.2014.313.
3
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.
Neurology. 2012 Feb 7;78(6):417-20. doi: 10.1212/WNL.0b013e318245f476. Epub 2012 Jan 25.
4
Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.
JAMA Neurol. 2015 Feb;72(2):201-8. doi: 10.1001/jamaneurol.2014.2950.
5
Mutations for Gaucher disease confer high susceptibility to Parkinson disease.
Arch Neurol. 2009 May;66(5):571-6. doi: 10.1001/archneurol.2009.72.
6
Association of mutations in the glucocerebrosidase gene with Parkinson disease in a Korean population.
Neurosci Lett. 2012 Apr 11;514(1):12-5. doi: 10.1016/j.neulet.2012.02.035. Epub 2012 Feb 22.
7
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
Brain. 2014 Dec;137(Pt 12):3235-47. doi: 10.1093/brain/awu291. Epub 2014 Oct 27.
8
Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling Settings.
J Genet Couns. 2017 Dec;26(6):1165-1172. doi: 10.1007/s10897-017-0123-6. Epub 2017 Jun 30.
9
Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutations.
Blood Cells Mol Dis. 2018 Feb;68:115-116. doi: 10.1016/j.bcmd.2016.11.007. Epub 2016 Nov 12.
10
Involvement of Gaucher Disease Mutations in Parkinson Disease.
Curr Protein Pept Sci. 2017;18(7):758-764. doi: 10.2174/1389203717666160311115956.

引用本文的文献

1
Penetrance of Parkinson's disease in GBA1 carriers depends on variant severity and polygenic background.
NPJ Parkinsons Dis. 2025 Jun 12;11(1):162. doi: 10.1038/s41531-025-00997-y.
2
Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease.
Mov Disord. 2024 Dec;39(12):2144-2154. doi: 10.1002/mds.30006. Epub 2024 Sep 11.
3
-Associated Parkinson's Disease Is a Distinct Entity.
Int J Mol Sci. 2024 Jun 28;25(13):7102. doi: 10.3390/ijms25137102.
5
Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic Variants.
Mov Disord. 2023 Dec;38(12):2155-2162. doi: 10.1002/mds.29647. Epub 2023 Nov 2.
6
Genetic Testing in Parkinson's Disease.
Mov Disord. 2023 Aug;38(8):1384-1396. doi: 10.1002/mds.29500. Epub 2023 Jun 27.
7
GBA1 Variants and Parkinson's Disease: Paving the Way for Targeted Therapy.
J Mov Disord. 2023 Sep;16(3):261-278. doi: 10.14802/jmd.23023. Epub 2023 Jun 12.
9
Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.
Int J Mol Sci. 2023 Mar 28;24(7):6338. doi: 10.3390/ijms24076338.
10
Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson's disease GBA-N370S dopamine neurons.
Cell Rep. 2023 Mar 28;42(3):112180. doi: 10.1016/j.celrep.2023.112180. Epub 2023 Mar 3.

本文引用的文献

1
A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers.
J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):853-4. doi: 10.1136/jnnp-2012-302402. Epub 2012 May 10.
2
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.
Neurology. 2012 Feb 7;78(6):417-20. doi: 10.1212/WNL.0b013e318245f476. Epub 2012 Jan 25.
3
Neurological manifestations in patients with Gaucher disease and their relatives, it is just a coincidence?
J Inherit Metab Dis. 2011 Jun;34(3):781-7. doi: 10.1007/s10545-011-9298-4. Epub 2011 Mar 8.
4
The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.
Blood Cells Mol Dis. 2011 Jan 15;46(1):95-102. doi: 10.1016/j.bcmd.2010.10.006. Epub 2010 Nov 10.
6
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.
N Engl J Med. 2009 Oct 22;361(17):1651-61. doi: 10.1056/NEJMoa0901281.
7
Mutations for Gaucher disease confer high susceptibility to Parkinson disease.
Arch Neurol. 2009 May;66(5):571-6. doi: 10.1001/archneurol.2009.72.
8
Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece.
Neurosci Lett. 2009 Mar 13;452(2):87-9. doi: 10.1016/j.neulet.2009.01.029. Epub 2009 Jan 15.
9
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations.
Arch Neurol. 2008 Oct;65(10):1353-7. doi: 10.1001/archneur.65.10.1353.
10
Carrier screening in individuals of Ashkenazi Jewish descent.
Genet Med. 2008 Jan;10(1):54-6. doi: 10.1097/GIM.0b013e31815f247c.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验